Avidity Biosciences, Inc. Common Stock

June closed on a high note for the stock market, with the S&P 500, tracked by the SPDR S&P 500 ETF Trust (NYSE:SPY), gaining 3.2%, despite significant disparities in sector and industry performances. The technology sector, as tracked by the Technology Select Sector SPDR Fund (NYSE:XLK), led the 11 S&P 500 sectors in performance last month, surging 7.7% and achieving its strongest monthly gain this year. In stark contrast, utilities lagged, with the Utilities Select Sector SPDR Fund (NYSE:XLU) dropping 6.3%, marking the worst month since September 2023. Top Performing Industry ETFs In June The iShares Expanded Tech-Software Sector ETF (NYSE:IGV) rallied 11.3% last month, topping the rankings among industry ETFs. Hot on its heels was the VanEck Semiconductor ETF (NYSE:SMH), which climbed 8.4%, showcasing strong momentum in the semiconductor sector. Since hitting its low ...Full story available on Benzinga.com

Related tickers: AVGO, SOXX, OLED, IGV, RNA, REZ, QRVO, SMH, SPY, CRWD, XBI, XLK, XLU, XSD, ADBE, ALNY, IBB, ORCL, SCLX, COPX.

Initial data from an early-stage study shows that treatment with Avidity's (RNA) experimental therapy could address the underlying cause of a rare muscle-weakening condition.

Related tickers: RNA, HRTX, MRNS, ARQT.